FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1964662020> ?p ?o ?g. }

• W1964662020 abstract "The aim of this study was to investigate whether neutrophil-guided dose escalation of anthracycline–cyclophosphamide-containing chemotherapy (ACC) for breast cancer is feasible, in order to optimize outcome. Breast cancer patients planned for 3-weekly ACC were enrolled in this study. The first treatment cycle was administered in a standard BSA-adjusted dose. The absolute neutrophil count was measured at baseline and at day 8, 11 and 15 after administration of ACC. For patients with none or mild (CTC grade 0–2) neutropenia and no other dose-limiting toxicity, we performed a 10–25 % dose escalation of the second cycle with the opportunity to a further 10–25 % dose escalation of the third cycle. Thirty patients were treated in the adjuvant setting with either FE100C (n = 23) or AC (n = 4), or in the palliative setting with FAC (n = 3). Two out of 23 patients (9 %) treated with FEC did not develop grade 3–4 neutropenia after the first treatment cycle. Dose escalation was performed in these two patients (30 % in one and 15 % in the other patient). During dose escalation, there were no complications like febrile neutropenia. No patients treated with FAC or AC could be escalated, since all of them developed grade 3–4 neutropenia. We conclude that asymptomatic grade 3–4 neutropenia is likely to be achieved in the majority of patients with breast cancer treated with ACC according to presently advocated BSA-based dose levels. Escalation of currently advocated ACC doses without G-CSF, with a target of grade 3–4 neutropenia, is feasible, but only possible in a small proportion of patients. EudraCT 2010-020309-33." @default.
• W1964662020 created "2016-06-24" @default.
• W1964662020 creator A5020510647 @default.
• W1964662020 creator A5024709204 @default.
• W1964662020 creator A5041299951 @default.
• W1964662020 creator A5047480637 @default.
• W1964662020 creator A5064453966 @default.
• W1964662020 date "2015-03-13" @default.
• W1964662020 modified "2023-09-26" @default.
• W1964662020 title "Neutrophil-guided dosing of anthracycline–cyclophosphamide-containing chemotherapy in patients with breast cancer: a feasibility study" @default.
• W1964662020 cites W1701849548 @default.
• W1964662020 cites W1944107108 @default.
• W1964662020 cites W1956345196 @default.
• W1964662020 cites W1973258451 @default.
• W1964662020 cites W2028940434 @default.
• W1964662020 cites W2031871398 @default.
• W1964662020 cites W2034949145 @default.
• W1964662020 cites W2037504528 @default.
• W1964662020 cites W2045634673 @default.
• W1964662020 cites W2047544514 @default.
• W1964662020 cites W2053543045 @default.
• W1964662020 cites W2072993212 @default.
• W1964662020 cites W2084654918 @default.
• W1964662020 cites W2091666474 @default.
• W1964662020 cites W2109828663 @default.
• W1964662020 cites W2116144791 @default.
• W1964662020 cites W2127118871 @default.
• W1964662020 cites W2127232551 @default.
• W1964662020 cites W2128458647 @default.
• W1964662020 cites W2138764684 @default.
• W1964662020 cites W2138991012 @default.
• W1964662020 cites W2158767575 @default.
• W1964662020 cites W2165999332 @default.
• W1964662020 cites W2168114725 @default.
• W1964662020 cites W2175322882 @default.
• W1964662020 cites W4234749243 @default.
• W1964662020 cites W4293719025 @default.
• W1964662020 doi "https://doi.org/10.1007/s12032-015-0550-x" @default.
• W1964662020 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4357644" @default.
• W1964662020 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25772511" @default.
• W1964662020 hasPublicationYear "2015" @default.
• W1964662020 type Work @default.
• W1964662020 sameAs 1964662020 @default.
• W1964662020 citedByCount "5" @default.
• W1964662020 countsByYear W19646620202017 @default.
• W1964662020 countsByYear W19646620202019 @default.
• W1964662020 countsByYear W19646620202020 @default.
• W1964662020 countsByYear W19646620202023 @default.
• W1964662020 crossrefType "journal-article" @default.
• W1964662020 hasAuthorship W1964662020A5020510647 @default.
• W1964662020 hasAuthorship W1964662020A5024709204 @default.
• W1964662020 hasAuthorship W1964662020A5041299951 @default.
• W1964662020 hasAuthorship W1964662020A5047480637 @default.
• W1964662020 hasAuthorship W1964662020A5064453966 @default.
• W1964662020 hasBestOaLocation W19646620201 @default.
• W1964662020 hasConcept C121608353 @default.
• W1964662020 hasConcept C126322002 @default.
• W1964662020 hasConcept C141071460 @default.
• W1964662020 hasConcept C143998085 @default.
• W1964662020 hasConcept C2776694085 @default.
• W1964662020 hasConcept C2776755627 @default.
• W1964662020 hasConcept C2776802502 @default.
• W1964662020 hasConcept C2777063308 @default.
• W1964662020 hasConcept C2777288759 @default.
• W1964662020 hasConcept C2777910003 @default.
• W1964662020 hasConcept C2778850193 @default.
• W1964662020 hasConcept C530470458 @default.
• W1964662020 hasConcept C71924100 @default.
• W1964662020 hasConcept C74133956 @default.
• W1964662020 hasConcept C90924648 @default.
• W1964662020 hasConceptScore W1964662020C121608353 @default.
• W1964662020 hasConceptScore W1964662020C126322002 @default.
• W1964662020 hasConceptScore W1964662020C141071460 @default.
• W1964662020 hasConceptScore W1964662020C143998085 @default.
• W1964662020 hasConceptScore W1964662020C2776694085 @default.
• W1964662020 hasConceptScore W1964662020C2776755627 @default.
• W1964662020 hasConceptScore W1964662020C2776802502 @default.
• W1964662020 hasConceptScore W1964662020C2777063308 @default.
• W1964662020 hasConceptScore W1964662020C2777288759 @default.
• W1964662020 hasConceptScore W1964662020C2777910003 @default.
• W1964662020 hasConceptScore W1964662020C2778850193 @default.
• W1964662020 hasConceptScore W1964662020C530470458 @default.
• W1964662020 hasConceptScore W1964662020C71924100 @default.
• W1964662020 hasConceptScore W1964662020C74133956 @default.
• W1964662020 hasConceptScore W1964662020C90924648 @default.
• W1964662020 hasIssue "4" @default.
• W1964662020 hasLocation W19646620201 @default.
• W1964662020 hasLocation W19646620202 @default.
• W1964662020 hasLocation W19646620203 @default.
• W1964662020 hasLocation W19646620204 @default.
• W1964662020 hasLocation W19646620205 @default.
• W1964662020 hasLocation W19646620206 @default.
• W1964662020 hasLocation W19646620207 @default.
• W1964662020 hasOpenAccess W1964662020 @default.
• W1964662020 hasPrimaryLocation W19646620201 @default.
• W1964662020 hasRelatedWork W1964662020 @default.
• W1964662020 hasRelatedWork W2020150632 @default.
• W1964662020 hasRelatedWork W2591616149 @default.
• W1964662020 hasRelatedWork W2695590130 @default.
• W1964662020 hasRelatedWork W2791179561 @default.

• next